<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
                        <id>https://portal.bioaro.com/new-news-feed</id>
                                <link href="https://portal.bioaro.com/new-news-feed" rel="self"></link>
                                <title><![CDATA[News-feed]]></title>
                    
                                <subtitle>The description of the feed.</subtitle>
                                                    <updated>2024-08-17T02:05:01-06:00</updated>
                        <entry>
            <title><![CDATA[DR. ANMOL KAPOOR: “CUSTOMIZED HEALTHCARE IMPROVES THE QUALITY OF LIFE”]]></title>
            <link rel="alternate" href="https://portal.bioaro.com/news/39bcae20-a20b-11ed-8d74-f9b4a8748fcf" />
            <id>https://portal.bioaro.com/39bcae20-a20b-11ed-8d74-f9b4a8748fcf</id>
            <author>
                <name><![CDATA[BioAro]]></name>
            </author>
            <summary type="html">
                <![CDATA[BioAro is gearing up to launch its state-of-the-art genetic and microbiome testing services, poised to revolutionize personalized medicine through a precision-based approach. By offering comprehensive testing services, the company aims to provide Canadians with a better understanding of their inherited and acquired health risks, empowering them to make informed decisions about their health and lifestyle.BioAro's specialized services offer a unique and unparalleled view into a patient's health, providing valuable insights that were previously unavailable. The company's testing services are based on evidence-based medical guidelines and are accompanied by education and support to ensure patients fully comprehend the implications of their results.In essence, BioAro offers a supercharged personalized healthcare experience, allowing patients to take control of their health and well-being like never before. With its innovative testing services and dedication to patient education, BioAro is set to transform the way Canadians approach their health, unlocking a new era of precision-based medicine.Read Full Article On Drishti Magazine ]]>
            </summary>
                                    <updated>2023-04-11T15:36:34-06:00</updated>
        </entry>
            <entry>
            <title><![CDATA[BioAro Inc. And CardiAI Launches Rapid PCR Testing Services in the Northwest Territories at Gahcho Kué Mine]]></title>
            <link rel="alternate" href="https://portal.bioaro.com/news/5ecfe120-9707-11ed-972a-6b8a4f8da77c" />
            <id>https://portal.bioaro.com/5ecfe120-9707-11ed-972a-6b8a4f8da77c</id>
            <author>
                <name><![CDATA[BioAro]]></name>
            </author>
            <summary type="html">
                <![CDATA[Lyndon Clark, General Manager of Gahcho Kué mine, emphasizes the importance of testing employees as a critical pillar in the mine's COVID-19 response. With the addition of PCR testing on-site, Gahcho Kué mine is able to bolster existing measures aimed at mitigating risks related to COVID-19, enhancing its ability to protect its employees, their families, and the surrounding communities in the NWT.The ability to conduct PCR testing on-site provides Gahcho Kué mine with an additional layer of protection against the virus. By regularly testing employees, the mine can quickly identify and isolate potential cases, limiting the spread of the virus and preventing outbreaks within the workforce.Overall, Gahcho Kué mine's comprehensive approach to COVID-19 mitigation, including on-site PCR testing, serves as an example of the mining industry's commitment to protecting its employees and surrounding communities amidst the ongoing pandemic.Read Full Article on Businesswire]]>
            </summary>
                                    <updated>2023-04-11T15:38:02-06:00</updated>
        </entry>
            <entry>
            <title><![CDATA[Calgarian takes charge of own health with genetic testing]]></title>
            <link rel="alternate" href="https://portal.bioaro.com/news/676368a0-c00f-11ed-ba9a-192ddc67b1fb" />
            <id>https://portal.bioaro.com/676368a0-c00f-11ed-ba9a-192ddc67b1fb</id>
            <author>
                <name><![CDATA[BioAro]]></name>
            </author>
            <summary type="html">
                <![CDATA[A man from Calgary is feeling let down by the healthcare system and is taking matters into his own hands by pursuing genetic testing to better understand his health. He believes that by getting a better understanding of his genetic makeup, he can take a more proactive approach to his healthcare and make informed decisions about his lifestyle and medical treatments.City News Report]]>
            </summary>
                                    <updated>2024-08-17T02:05:01-06:00</updated>
        </entry>
            <entry>
            <title><![CDATA[Genomics is helping improve diagnosis and treatment for heart patients]]></title>
            <link rel="alternate" href="https://portal.bioaro.com/news/a519c6c0-adca-11ed-a055-2fcd427ff38c" />
            <id>https://portal.bioaro.com/a519c6c0-adca-11ed-a055-2fcd427ff38c</id>
            <author>
                <name><![CDATA[BioAro]]></name>
            </author>
            <summary type="html">
                <![CDATA[Genetic factors often play a role in the development of heart disease, making genetic testing an important tool in the fight against this deadly condition. Calgary-based biotechnology company, BioAro Inc., is committed to helping patients with heart disease as well as individuals who may be at higher risk of developing it.As we recognize Heart Month, it's important to note that cardiovascular diseases continue to grow every year, affecting over three million Canadians, with over 750,000 Canadians living with heart failure. Additionally, more than 100,000 Canadians are diagnosed with heart failure annually, underscoring the urgent need for innovative solutions that can help identify and treat this life-threatening condition.With its advanced genetic testing services, BioAro Inc. is leading the charge in precision-based medicine, enabling healthcare providers to develop personalized treatment plans that can address patients' unique risk factors and improve their outcomes. As we continue to raise awareness about the importance of heart health, BioAro's commitment to advancing the field of genomics and precision health is sure to play a critical role in helping individuals live longer, healthier lives.Read Full Article on The Star Calgary]]>
            </summary>
                                    <updated>2023-04-11T15:33:05-06:00</updated>
        </entry>
            <entry>
            <title><![CDATA[BioAro Launches Its Genomics And Microbiome]]></title>
            <link rel="alternate" href="https://portal.bioaro.com/news/aa0b69d0-9706-11ed-ac5d-1ba9da2e597a" />
            <id>https://portal.bioaro.com/aa0b69d0-9706-11ed-ac5d-1ba9da2e597a</id>
            <author>
                <name><![CDATA[BioAro]]></name>
            </author>
            <summary type="html">
                <![CDATA[BioAro, a leading genomics and precision health company, is set to launch its comprehensive genetic and microbiome testing services. With BioAro's innovative testing, Canadians and Albertans can gain insight into their inherited and acquired health risks, and healthcare providers can recommend personalized treatments and lifestyle choices based on the results.Unlike other direct-to-consumer genetic testing companies, BioAro sequences and develops a map of your entire genome, specifically analyzing over 20,000 genes known to be involved in various diseases. This allows for a more detailed and comprehensive analysis, providing a more complete picture of an individual's health risks and potential genetic predispositions.By offering advanced testing and analysis services, BioAro is at the forefront of precision-based medicine, providing patients with the knowledge they need to make informed decisions about their health and well-being. With its dedication to providing personalized care and tailored treatments, BioAro is set to transform the healthcare landscape, bringing cutting-edge genomic and microbiome testing services to Canadians and beyond.Read Full Article on CISION]]>
            </summary>
                                    <updated>2023-04-11T15:39:09-06:00</updated>
        </entry>
            <entry>
            <title><![CDATA[BioAro is the first Canadian company to launch comprehensive genetic testing panels for various heart diseases]]></title>
            <link rel="alternate" href="https://portal.bioaro.com/news/e2f612e0-a924-11ed-b81d-0b9bcb69c03f" />
            <id>https://portal.bioaro.com/e2f612e0-a924-11ed-b81d-0b9bcb69c03f</id>
            <author>
                <name><![CDATA[BioAro]]></name>
            </author>
            <summary type="html">
                <![CDATA[Cardiovascular diseases continue to be a significant health concern in Canada, affecting over 3 million Canadians, with over 750,000 individuals living with heart failure. Heart failure touches the lives of almost 1 in 3 Canadians, and over 100,000 new cases are diagnosed annually. The death rate for adults aged 20 and over with heart disease is three times higher than for those without, and this risk increases to over six times higher for adults aged 40 and over with a diagnosis of heart failure.Men are twice as likely as women to suffer a heart attack, and they are often diagnosed with heart disease a decade earlier than women. These concerning statistics underscore the importance of innovative solutions, such as genetic testing and precision medicine, that can help identify and treat individuals at risk of developing heart disease, and ultimately improve outcomes for those already living with the condition.As healthcare providers and researchers continue to work towards new treatments and interventions, it's important to raise awareness about heart health and encourage individuals to take proactive steps to protect their hearts, such as regular exercise, healthy eating, and regular check-ups with their doctors.Read Full Article on Newswire]]>
            </summary>
                                    <updated>2023-04-11T15:34:51-06:00</updated>
        </entry>
    </feed>
